SPY410.90-0.59 -0.14%
DIA336.88-0.98 -0.29%
IXIC13,838.95-61.24 -0.44%

Catalent plans to expand production of J&J COVID-19 vaccine in Italy - WSJ

Catalent plans to expand production of J&J COVID-19 vaccine in Italy - WSJ

· 03/16/2021 21:04
Catalent plans to expand production of J&J COVID-19 vaccine in Italy - WSJ

- Catalent Inc CTLT.N plans to expand its COVID-19 vaccine production in Europe that will enable it to make more doses of Johnson & Johnson's JNJ.N shot, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

The contract drug manufacturer will bring online a second J&J vaccine production line at its plant in Anagni, Italy, during the fourth quarter, the Journal reported.


(Reporting by Aakriti Bhalla in Bengaluru; editing by Uttaresh.V)

((Aakriti.Bhalla@thomsonreuters.com;))